Myriad Genetics Logo
International
  • Home
  • Treating Diseases
    • Breast Cancer
    • Ovarian Cancer
    • Colon Cancer
    • Uterine Cancer
    • Melanoma
    • Pancreatic Cancer
    • Prostate Cancer
  • Patients
    • MySupport360
    • Hereditary 101
    • Learn About Genetic Testing
      • Populations At Risk
      • Genetic Testing Benefits
      • Reducing Your Risk
      • Genetic Testing FAQs
      • Your Privacy
    • Hereditary Cancer Quiz
    • Myriad Promise
    • Advocacy
    • Patient Speakers
    • Patient Resources
    • Common Myths and Facts about Gene Patents
  • Physicians
    • MyriadPro.com
    • Genetic Testing
      • Genetic Testing Process
      • Genetic Test Results
    • Prognostic Medicine
      • Prostate Cancer
    • Personalized Medicine
      • 5-FU Dose Optimization
      • Managing Chemotoxicity
    • Financial Assistance
    • Common Myths and Facts about Gene Patents
  • Products
    • Breast Cancer/Ovarian Cancer
    • Colon Cancer
    •  
    • Melanoma
    • Pancreatic Cancer
    • Prostate Cancer
    • 5-FU Dose Optimization
    • Managing Chemotoxicity
    • PTEN Testing
  • Future Innovations
    • Myriad RBM
    • Product Pipeline
    • Partnering and Licensing
    • Companion Diagnostics
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Reporting
      • Latest Earnings Release
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
      • Request Investor Information
    • Frequently Asked Questions
    • Contact
  • Careers
    • Current Openings
    • Benefits
    • Culture
    • Diversity & EEO
    • Utah and Myriad
  • About Myriad
    • History
    • Community
    • Myriad International
    • Management Team
    • Board of Directors
    • Media Center
      • Company Statement
      • BRACAnalysis By The Numbers
      • Social Media
      • Video Library
    • Location & Directions
      • Directions to Myriad
      • Directions to Myriad RBM
      • Directions to Myriad INT
    • Contact Us
  • Home
  • Treating Diseases
    • Treating Diseases
      • Breast Cancer
      • Ovarian Cancer
      • Colon Cancer
      • Uterine Cancer
      • Melanoma
      • Pancreatic Cancer
      • Prostate Cancer
  • Patients
    • Patients
      • MySupport360
      • Hereditary 101
      • Learn About Genetic Testing
      • Hereditary Cancer Quiz
      • Myriad Promise
      • Advocacy
      • Patient Speakers
      • Patient Resources
      • Common Myths and Facts about Gene Patents
  • Physicians
    • Physicians
      • MyriadPro.com
      • Genetic Testing
      • Prognostic Medicine
      • Personalized Medicine
      • Financial Assistance
      • Common Myths and Facts about Gene Patents
  • Products
    • Products
      • Breast Cancer/Ovarian Cancer
      • Colon Cancer
      • Melanoma
      • Pancreatic Cancer
      • Prostate Cancer
      • 5-FU Dose Optimization
      • Managing Chemotoxicity
      • PTEN Testing
  • Future Innovations
    • Future Innovations
      • Myriad RBM
      • Product Pipeline
      • Partnering and Licensing
      • Companion Diagnostics
  • Investor Relations
    • Investor Relations
      • Press Releases
      • Events & Presentations
      • Corporate Governance
      • Financial Reporting
      • Stock Information
      • Frequently Asked Questions
      • Contact
  • Careers
    • Careers
      • Current Openings
      • Culture
      • Diversity and EEO
      • Utah and Myriad
  • About Myriad
    • About Myriad
      • History
      • Community
      • Myriad International
      • Management Team
      • Board of Directors
      • Media Center
      • Location & Directions
      • Contact Us
  • Myriad International
  • Myriad Genetics /
  • Investor Relations /
  • News
  • Investor Relations
  • Contact
  • Corporate Actions
    • Board of Directors
    • Committees
    • Management Team
  • Corporate Governance
  • Events & Presentations
    • Archives
    • Presentations
    • Upcoming Events
  • FAQs
  • Financial Reporting
    • Annual Reports
    • Key Ratios
    • Latest Earnings Release
    • Quarterly Results
    • SEC Filings
  • Frequently Asked Questions
  • Myriad at a glance
  • Myriad At A Glance
  • News
  • Press Releases
  • Stock Information
    • Analyst Coverage
    • Dividend History
    • Historic Stock Lookup
    • Investment Calculator
    • Request Investor Information
    • Shareholder Services

Recent Posts

  • Melanoma – All Year
  • Melanoma – Know How to Protect Yourself
  • Melanoma – Know Your Skin
  • Your Genes are a Work of Art!
  • Melanoma – Know Your Risk

Archives

  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • July 2012
  • Home
  • Terms of Use
  • Privacy Policy
  • Safe Harbor Policy
  • Site Map
  • Contact Us

Copyright © 2013 Myriad Genetics
all rights reserved

Info: (800) 469-7423

Myriad Twitter Myriad Facebook